Showing results (5631-5640 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|April 2, 2024
Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter ProgramKe Zhou, Martine Bellanger, Louise Crivelli, et al.
The Oncologist|October 24, 2023
Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World StudyJianwei Liu, Xiaodong Zhu, Yangxun Pan, et al.
The Oncologist|September 8, 2023
Outcomes in Premenopausal Patients with HR+/HER2- Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence ScoreNadeem Bilani, Rima Patel, Fionnuala Crowley, et al.
The Oncologist|September 5, 2023
Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural DiseaseRi Sa, Taiyu Yang, Zexu Zhang, et al.
The Oncologist|September 12, 2023
Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled TrialNitai D Mukhopadhyay, Adam Khorasanchi, Sudeep Pandey, et al.
The Oncologist|March 30, 2026
Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative studyDina N Lokhorst, Bart J F van den Bemt, Yolba Smit, et al.
The Oncologist|April 30, 2026
Watchful Waiting in Children with Unifocal Osseous Langerhans Cell HistiocytosisChenxin Zhou, Haixia Yang, Shilin Liu, et al.
The Oncologist|April 14, 2026
Impact of geriatric covariates on metronomic cyclophosphamide efficacy and tolerance-the CHEMETROLD studyClara Griffe, Christine Ravot, David Dayde, et al.
The Oncologist|March 30, 2026
Minimal Residual Disease Assessment Through ctDNA Facilitates Tailored Immunotherapy in MSI-High, NTRK1-Fusion Pancreatic AdenocarcinomaSarah Rohlfing, Dilyana Vladimirova, Stephanie Berger, et al.
The Oncologist|November 25, 2018
Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional SurvivalQi-Yue Chen, Qing Zhong, Wei Wang, et al.
Pageof 571